ALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of Asabys

by Asabys Partners

ALLOX, a techbio company developing a proprietary technology to design new drugs targeting allosteric sites within oncology and other diseases, announces its incorporation today, as well as the succes...

Read more

Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys

by Asabys Partners

Nuage Therapeutics (“Nuage”) announces today the successful closing of a €12 million Seed financing to support the development of its lead program and validate its pioneering drug discovery plat...

Read more

SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline

by Ysios Capital

SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The fina...

Read more

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys

by IRB Barcelona - Instituto de Investigación Biomédica

Nuage Therapeutics has announced the closing of a financing round by Sabadell Asabys, the investment vehicle managed by Asabys Partners. With this injection of capital, the spin-off will start its w...

Read more

Splice Bio, backed by Ysios Capital, Asabys Partners and Caixa Capital Risc, appoints Jean-Philippe Combal as Chairman of the Board of Directors

by Ysios Capital

Splice Bio, a gene therapy company based on technology developed in the Muir Lab at Princeton University, announced today that it has appointed JeanPhilippe Combal as Chairman of its Board of Director...

Read more

ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio

by Ysios Capital

Splice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, announced today a new investment into the Company led by Ysios Capital and joined by Asabys Partner...

Read more

Origo Biopharma raises 2,3M€ in Series Seed financing with the participation from Sabadell Asabys, XesGalicia and the founding shareholders

by Asabys Partners

Origo Bio​pharm​a has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell As​abys, XesGalicia and the founding shareholders. The financing, led ...

Read more

La inversión en las startups de las ciencias de la vida y la salud en Cataluña supera por cuarto año consecutivo los 100 millones de euros

by Biocat

El “Estudio de inversión en el sector de las ciencias de la vida y la salud en Cataluña 2020” revela la buena salud del ecosistema, que casi ha igualado durante el primer semestre de 2020 el cap...

Read more

Sabadell Asabys y Alta Life Sciences lideran una ronda en INBRAIN Neuroelectronics. Acuden Finaves, el ICF y otros accionistas ya presentes en la compañía

by Inbrain Neuroelectronics

Asabys y Alta han liderado la inversión en INBRAIN para desarrollar una tecnología basada en Grafeno para la modulación electrónica neuronal que permite, tras la implantación intracerebral de un ...

Read more

ANACONDA BIOMED S.L. secures €20 Million round of funding

by Anaconda BioMed

​Anaconda​ Biomed S.L., a medical technology company developing next-generation th​rombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding w...

Read more

La spin-off del IRB Barcelona Ona Therapeutics arranca de la mano de Sabadell Asabys

by IRB Barcelona - Instituto de Investigación Biomédica

Ona Therapeutics, spin-off del IRB Barcelona e ICREA, ha sido fundada por los investigadores Salvador Aznar-Benitah y Valerie Vanhooren tras la inversión liderada por Sabadell Asabys. La empresa, co...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Anti-cancer drug could improve symptoms ...

by Universitat Autònoma de Barcelona (UAB)

It has been demonstrated in animal models the benefits of vorinostat a...

Photos Stream